Welcome to IntelGenX

We Make Approved Drugs Better

Leaders in Oral Thin Films

Cutting-Edge Technology

Creating Business Opporunities

Addressing Unmet Medical Needs

TSX-V: IGX 0.28 +0.01 +3.7% Volume: 1,601 August 7, 2020
OTCQX: IGXT 0.21 -0.01 -2.63% Volume: 89,069 August 7, 2020

Why invest in IntelGenx

Our business strategy is to apply our drug delivery technologies to improve existing drug compounds with proven efficacy and safety and, in conjunction with strategic development and distribution partners, reintroduce these drug compounds to the market as branded products with improved deliverability and efficacy. Because we are developing improved formulations of currently marketed therapeutics, our products typically require fewer clinical trials to generate the safety and efficacy data needed to achieve regulatory approval than drug formulations that have not been previously marketed. As a result, we believe we can accelerate development and reduce risk compared to traditional pharmaceutical and biotechnology companies.


There are no upcoming events to display.
Grand Opening